Summary
Pharmacology and pharmaceutical sciences encompass the integrated study of how chemical agents interact with biological systems to produce therapeutic and adverse effects, and the design and development of dosage forms that safely deliver these agents to their targets. Drug discovery combines target identification, high-throughput screening and medicinal chemistry to isolate bioactive compounds. Formulation science applies pharmaceutics principles to engineer tablets, injectables, liposomes and other carriers optimising stability, bioavailability and patient adherence. Pharmacokinetic and pharmacodynamic modelling characterises absorption, distribution, metabolism and excretion, correlating systemic exposure with therapeutic indices and toxicity thresholds. Advanced delivery systems—prodrugs, nanoparticles, controlled-release matrices and ligand-guided platforms—harness physiological cues and nano-scale engineering to concentrate therapies at disease sites while sparing healthy tissues. Analytical techniques such as mass spectrometry and nuclear magnetic resonance ensure molecular integrity and facilitate in-vivo–in-vitro correlations. Regulatory science and manufacturing standards govern translation of laboratory innovations into approved medicines. Emerging approaches—artificial intelligence for virtual screening, polypharmacology, genomic-guided personalised formulations and continuous manufacturing—promise to accelerate development and broaden global access to high-quality therapeutics.
Research from Nature Portfolio
A self-assembled trio-pharmacophore DNA-encoded library combined three pre-purified sub-libraries to co-select optimal fragment–linker–fragment combinations. By templating chemical ligation through DNA-templated synthesis, a library exceeding three hundred million members was generated without exceeding drug-like molecular weights. Screening against proteolytic enzymes and matrix metalloproteases yielded novel high-affinity inhibitors, illustrating de novo hit discovery through dual-fragment optimisation.
Transient glycolysis inhibition by 2-deoxy-D-glucose, combined with locoregional microwave ablation in preclinical breast cancer models, promoted differentiation of long-lived central memory CD8+ T cells. Single-cell transcriptomics revealed a STAT1-dependent reprogramming of peripheral T-cell metabolism, enhancing durable tumour control and resistance to recurrence, and laying the groundwork for combining metabolic priming with minimally invasive ablative therapies.
Microfluidic vortex focusing enabled continuous, high-throughput synthesis of size-tunable liposomes down to 27 nm at production rates above 20 g h–1. By establishing a vortical flow around an axisymmetric lipid stream, this single-device process achieved precise size control with low variance, offering a scalable route to uniform vesicles for drug delivery applications.
Topic trend for the past 5 years
The graph below shows the article count in Nature Index journals for pharmacology and pharmaceutical sciences.
* The ‘Current Index’ represents data for a 12-month rolling window, the current window is 1 May 2025 - 30 April 2026.
Technical terms
DNA-encoded library: A collection of small molecules each linked to a unique DNA tag that records its synthetic history, allowing pooled synthesis and high-throughput affinity screening by DNA sequencing.
Split-and-pool synthesis: A combinatorial approach in which mixtures are divided (“split”), each subset modified by different reagents, then recombined (“pooled”) and re-split in subsequent steps, generating large tagged libraries.
Central memory CD8+ T cells (TCM): A lymphocyte subset with high CD44 and CD62L expression that confers long-term immune protection and rapid recall responses after antigen re-exposure.
Probability of target attainment (PTA): The proportion of a population predicted to achieve or exceed a predefined pharmacokinetic exposure index (e.g., AUC) at a given dosing regimen.
Population pharmacokinetic model: A nonlinear mixed-effects framework quantifying typical pharmacokinetic parameters (clearance, volume) and their variability across individuals, identifying influential covariates.
Microfluidic vortex focusing: A continuous-flow technique in which vortical flow around a lipid stream induces rapid convective mixing, enabling precise, scalable production of size-defined liposomes.
Notable articles in pharmacology and pharmaceutical sciences
- Trio-pharmacophore DNA-encoded chemical library for simultaneous selection of fragments and linkers. Nature Communications (2023).
- Glycolysis inhibition induces anti-tumor central memory CD8+T cell differentiation upon combination with microwave ablation therapy. Nature Communications (2024).
- Microfluidic vortex focusing for high throughput synthesis of size-tunable liposomes. Nature Communications (2022).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Research
Position of Pharmacology and Pharmaceutical Sciences in Nature Index by Count
Leading institutions
| Institution | Count | Share |
|---|---|---|
| Chinese Academy of Sciences (CAS) | 151 | 40.29 |
| Zhejiang University (ZJU) | 56 | 30.02 |
| Harvard University | 77 | 25.21 |
| Shanghai Jiao Tong University (SJTU) | 58 | 21.82 |
| Sichuan University (SCU) | 35 | 20.56 |
| China Pharmaceutical University (CPU) | 28 | 19.72 |
| Fudan University | 45 | 18.18 |
| Peking University (PKU) | 58 | 18.14 |
| Huazhong University of Science and Technology (HUST) | 23 | 15.92 |
| Massachusetts Institute of Technology (MIT) | 34 | 15.42 |
Leading countries/territories
| Countries/territories | Count | Share |
|---|---|---|
| China | 826 | 763.58 |
| United States of America (USA) | 604 | 444.22 |
| United Kingdom (UK) | 140 | 65.43 |
| Germany | 116 | 58.9 |
| South Korea | 57 | 37.68 |
| Canada | 74 | 37.48 |
| Japan | 57 | 33.34 |
| India | 40 | 28.07 |
| Denmark | 48 | 26.45 |
| Netherlands | 58 | 25.12 |
Collaboration
Top 5 leading collaborators in Pharmacology and Pharmaceutical Sciences
Collaborating institutions
Note: Hover over the bars to view details about each institution's Share.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.